Omzo vs Trimi: Compounded GLP-1 Plans and Pricing Compared
Comparing Omzo vs Trimi quickly: Omzo focuses on clinician-guided plans with compounded semaglutide starting at $179 and an option for prescriptions for branded medications, while Trimi emphasizes flat monthly pricing from $99/mo, free overnight shipping, and a 6-month money-back promise. Early verdict: choose Trimi for predictable flat pricing and shipping or Omzo if you want clinician-reviewed access and the option to receive a prescription for branded drugs.
Visit Omzo to review clinician-guided plans
How Omzo vs Trimi differ at a glance
This comparison focuses on five distinctive differences supported by the source: pricing model, shipping and delivery, medication options and regulatory status, clinical oversight and medical network, and guarantees or refunds. Each section compares the providers directly using only the supplied evidence.
Pricing model and starting costs
Omzo lists personalized compounded semaglutide starting at $179 and tirzepatide starting at $279. Trimi advertises compounded semaglutide from $99/month on its annual plan and tirzepatide at $125/month, with flat pricing that does not rise as dose increases. In short, Omzo presents per-treatment starting prices while Trimi promotes an all doses same price monthly model.
Shipping and fulfillment
Trimi highlights free overnight, temperature controlled shipping and free overnight shipping for its medications. Omzo states fast, discreet delivery but does not specify overnight shipping in the captured evidence. If shipping speed and temperature control are priorities, Trimi documents free overnight shipping.
Medication options and regulatory notes
Both providers offer compounded semaglutide and tirzepatide prescribed by U.S. clinicians. Omzo emphasizes a Compounded Medication Program that uses state licensed sterile compounding pharmacies and clearly notes that these compounded drugs are not FDA approved. Omzo also states providers may write prescriptions for FDA approved branded medications but Omzo does not sell, dispense, or ship branded meds; patients fill those prescriptions at their chosen pharmacy. Trimi likewise notes its compounded medications are not themselves FDA approved and are prepared per individual prescription. Trimi additionally names compounding pharmacies and makes a certificate of analysis available on request.
Clinical oversight and provider networks
Omzo connects users with licensed U.S. providers and states clinical services are provided by third party networks of U.S. licensed clinicians who determine eligibility. Omzo notes providers make the final determination on prescriptions and that the website assessment does not create a doctor patient relationship. Trimi cites medical oversight from Arora Health led by Dr. Sean Arora and describes a nationwide clinical network; it says a board certified physician founded the clinical network and that providers review and prescribe across all 50 states. Both emphasize licensed U.S. clinicians but Trimi supplies named clinical leadership in the captured evidence.
Guarantees, refunds, and membership details
Trimi advertises a 6-month money-back promise where, if not approved by the medical team, there is a 100 percent automatic refund and a 6-month refund policy for lack of weight loss under terms. Omzo includes disclaimers that individual results vary and no guarantees of weight loss are made. Neither provider guarantees eligibility or outcomes and both note pricing, eligibility, pharmacy, state coverage, and renewal terms may change.
Direct comparison table
| Criteria | Omzo | Trimi |
|---|---|---|
| Starting price | $179 for semaglutide; $279 for tirzepatide | $99/month semaglutide on annual plan; $125/month tirzepatide |
| Pricing model | Personalized compounded pricing and clinician-guided plans | Flat monthly pricing that does not rise with dose |
| Shipping | Fast, discreet delivery | Free overnight, temperature controlled shipping |
| Medication options | Compounded medications; providers may prescribe branded meds but Omzo does not sell or ship branded meds | Compounded semaglutide and tirzepatide; named compounding pharmacies and certificate of analysis available on request |
| Regulatory note | Compounded medications are not FDA approved | Compounded medications are not FDA approved |
| Clinical oversight | Licensed U.S. providers via third party networks; providers determine eligibility | Clinical oversight by Arora Health network led by Dr. Sean Arora; licensed providers across all 50 states |
| Refunds or guarantees | No guarantee of results; eligibility not guaranteed | 6-month money-back promise and automatic refund if not approved by the medical team; terms apply |
Compare Omzo medication options
What to consider when choosing
Decide whether you prefer Omzo or Trimi based on the evidence presented. If predictable, flat monthly pricing and documented overnight shipping are important, Trimi explicitly lists those features along with named compounding pharmacies and a 6-month refund promise. If you value clinician-guided plans with the option that a provider may write a prescription for branded FDA approved medications and a per-treatment starting price disclosure, Omzo documents those elements and the clinician review process.
Explore Trimi membership and refund policy
Choose one if…
- Choose Trimi if you want flat pricing from $99/month on an annual plan, free overnight shipping, named compounding pharmacies, and a 6-month money-back promise as described in the source.
- Choose Omzo if you prefer clinician-guided plans reviewed by licensed U.S. providers, compounded semaglutide starting at $179, and the option for a provider to prescribe branded medications that you would fill at your pharmacy.
Both providers note compounded medications are not FDA approved and that eligibility, pricing, and availability may change. Confirm eligibility, medication options, total cost, renewal terms, and state availability directly with each provider before enrollment.